Modeling human disease in rodents by CRISPR/Cas9 genome editing

Mammalian Genome

Volumn 28, Issue 7-8, 2017, Pages 291-301

  Birling, Marie Christine ^a   Herault, Yann ^a,b,c,d   Pavlovic, Guillaume ^a  

^a INSTITUT CLINIQUE DE LA SOURIS   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c CNRS   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER MODEL; COPY NUMBER VARIATION; CRISPR-CAS9 SYSTEM; GENE EDITING; HUMAN; HUMAN GENOME; IN VITRO STUDY; IN VIVO STUDY; MOUSE MODEL; NONHUMAN; PERSONALIZED MEDICINE; RODENT MODEL; ANIMAL; BIOLOGICAL MODEL; CRISPR CAS SYSTEM; DISEASE MODEL; GENE THERAPY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETIC VARIATION; GENOMICS; MOUSE; MULTIFACTORIAL INHERITANCE; OPEN READING FRAME; PROCEDURES; REGULATORY RNA SEQUENCE; TRANSGENIC ANIMAL;

UNTRANSLATED RNA;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CRISPR-CAS SYSTEMS; DISEASE MODELS, ANIMAL; GENE EDITING; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC THERAPY; GENETIC VARIATION; GENOMICS; HUMANS; MICE; MODELS, BIOLOGICAL; MULTIFACTORIAL INHERITANCE; OPEN READING FRAMES; PRECISION MEDICINE; REGULATORY SEQUENCES, RIBONUCLEIC ACID; RNA, UNTRANSLATED;

EID: 85021823775     PISSN: 09388990     EISSN: 14321777     Source Type: Journal    
DOI: 10.1007/s00335-017-9703-x     Document Type: Article

References (83)

1. Adams DJ, Biggs PJ, Cox T, Davies R, van der Weyden L, Jonkers J, Smith J, Plumb B, Taylor R, Nishijima I et al (2004) Mutagenic insertion and chromosome engineering resource (MICER). Nat Genet 36:867–871
2. Bailey JA, Yavor AM, Massa HF, Trask BJ, Eichler EE (2001) Segmental duplications: organization and impact within the current human genome project assembly. Genome Res 11:1005–1017
3. Barau J, Teissandier A, Zamudio N, Roy S, Nalesso V, Hérault Y, Guillou F, Bourc’his D (2016) The DNA methyltransferase DNMT3C protects male germ cells from transposon activity. Science 354:909–912
4. Bilovocky NA, Romito-DiGiacomo RR, Murcia CL, Maricich SM, Herrup K (2003) Factors in the genetic background suppress the engrailed-1 cerebellar phenotype. J Neurosci Off J Soc Neurosci 23:5105–5112
5. Birling M-C, Schaeffer L, André P, Lindner L, Maréchal D, Ayadi A, Sorg T, Pavlovic G, Hérault Y (2017) Efficient and rapid generation of large genomic variants in rats and mice using CRISMERE. Sci Rep 7:43331
6. Boroviak K, Doe B, Banerjee R, Yang F, Bradley A (2016) Chromosome engineering in zygotes with CRISPR/Cas9: chromosome engineering in zygotes with CRISPR/Cas9. Genesis 54:78–85
7. Bradley A, Anastassiadis, K., Ayadi A, Battey JF, Bell C, Birling M-C, Bottomley J, Brown SD, Bürger A, Bult CJ et al (2012) The mammalian gene function resource: the international knockout mouse consortium. Mamm Genome 23: 580–586
8. Brown SDM, Moore MW (2012) The international mouse phenotyping consortium: past and future perspectives on mouse phenotyping. Mamm Genome 23:632–640
9. Buffenstein R, Nelson OL, Corbit KC (2014) Questioning the preclinical paradigm: natural, extreme biology as an alternative discovery platform. Aging 6:913–920
10. Carneiro AMD, Airey DC, Thompson B, Zhu C-B, Lu L, Chesler EJ, Erikson KM, Blakely RD (2009) Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypes. Proc Natl Acad Sci USA 106:2047–2052
11. Churchill GA, Airey DC, Allayee H, Angel JM, Attie AD, Beatty J, Beavis WD, Belknap JK, Bennett B, Berrettini W et al (2004) The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet 36:1133–1137
12. Collins FS, Tabak LA (2014) Policy: NIH plans to enhance reproducibility. Nature 505:612–613
13. Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y, Aerts J, Andrews TD, Barnes C, Campbell P et al (2010) Origins and functional impact of copy number variation in the human genome. Nature 464:704–712
14. Cook EH, Scherer SW (2008) Copy-number variations associated with neuropsychiatric conditions. Nature 455:919–923
15. Courtney DG, Moore JE, Atkinson SD, Maurizi E, Allen EHA, Pedrioli DML, McLean WHI, Nesbit MA, Moore CBT (2015) CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting. Gene Ther 23:108–112
16. Dasouki MJ, Lushington GH, Hovanes K, Casey J, Gorre M (2011) The 3q29 microdeletion syndrome: report of three new unrelated patients and in silico “RNA binding” analysis of the 3q29 region. Am J Med Genet A 155 A, 1654–1660.
17. de Angelis HM, Nicholson G, Selloum M, White JK, Morgan H, Ramirez-Solis R, Sorg T, Wells S, Fuchs H, Fray M et al (2015a) Analysis of mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics. Nat Genet 47:969–978
18. de Angelis MH, Nicholson G, Selloum M, White JK, Morgan H, Ramirez-Solis R, Sorg T, Wells S, Fuchs H, Fray M et al (2015b) Analysis of mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics. Nat Genet 47:969–978
19. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG et al (2012) The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 22:1775–1789
20. Dickinson ME, Flenniken AM, Ji X, Teboul L, Wong MD, White JK, Meehan TF, Weninger WJ, Westerberg H, Adissu H et al (2016) High-throughput discovery of novel developmental phenotypes. Nature 537:508–514
21. Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F, Epstein CB, Frietze S, Harrow J, Kaul R et al (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489:57–74
22. Eisener-Dorman AF, Lawrence DA, Bolivar VJ (2009. Cautionary insights on knockout mouse studies: the gene or not the gene? Brain Behav Immun 23:318–324)
23. European Commission (2013) Seventh Report on the Statistics on the Number of Animals used for Experimental and other Scientific Purposes in the Member States of the European Union (European Commission)
24. Fanciulli M, Norsworthy PJ, Petretto E, Dong R, Harper L, Kamesh L, Heward JM, Gough SCL, de Smith A, Blakemore AIF et al (2007) FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 39:721–723
25. Feuk L, Carson AR, Scherer SW (2006) Structural variation in the human genome. Nat Rev Genet 7:85–97
26. Frankish A, Harrow J (2014) GENCODE pseudogenes. Methods Mol Biol Clifton NJ 1167:129–155
27. Freeman JL, Perry GH, Feuk L, Redon R, McCarroll SA, Altshuler DM, Aburatani H, Jones KW, Tyler-Smith C, Hurles ME et al (2006) Copy number variation: new insights in genome diversity. Genome Res 16:949–961
28. Gandal MJ, Leppa V, Won H, Parikshak NN, Geschwind DH (2016) The road to precision psychiatry: translating genetics into disease mechanisms. Nat Neurosci 19:1397–1407
29. Girirajan S, Brkanac Z, Coe BP, Baker C, Vives L, Vu TH, Shafer N, Bernier R, Ferrero GB, Silengo M et al (2011) Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet 7:e1002334
30. Gregorová S, Divina P, Storchova R, Trachtulec Z, Fotopulosova V, Svenson KL, Donahue LR, Paigen B, Forejt J (2008) Mouse consomic strains: exploiting genetic divergence between Mus m. musculus and Mus m. domesticus subspecies. Genome Res 18:509–515
31. Guo MH, Nandakumar SK, Ulirsch JC, Zekavat SM, Buenrostro JD, Natarajan P, Salem RM, Chiarle R, Mitt M, Kals M et al (2016) Comprehensive population-based genome sequencing provides insight into hematopoietic regulatory mechanisms. Proc Natl Acad Sci 114:E327–E336
32. Hérault Y, Rassoulzadegan M, Cuzin F, Duboule D (1998) Engineering chromosomes in mice through targeted meiotic recombination (TAMERE). Nat Genet 20:381–384
33. Hubbard J, Ruppert E, Calvel L, Robin-Choteau L, Gropp C-M, Allemann C, Reibel S, Sage-Ciocca D, Bourgin P (2015) Arvicanthis ansorgei, a novel model for the study of sleep and waking in diurnal rodents. Sleep. doi: 10.5665/sleep.4754
34. Huddleston J, Eichler EE (2016) An Incomplete Understanding of Human Genetic Variation. Genetics 202:1251–1254
35. Itsara A, Cooper GM, Baker C, Girirajan S, Li J, Absher D, Krauss RM, Myers RM, Ridker PM, Chasman DI et al (2009) Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet 84:148–161
36. Justice MJ, Dhillon P (2016) Using the mouse to model human disease: increasing validity and reproducibility. Dis Model Mech 9:101–103
37. Kafkafi N, Golani I, Jaljuli I, Morgan H, Sarig T, Würbel H, Yaacoby S, Benjamini Y (2017) Addressing reproducibility in single-laboratory phenotyping experiments. Nat Methods 14:462–464
38. Koirala P, Huang J, Ho T-T, Wu F, Ding X, Mo Y-Y (2017) LncRNA AK023948 is a positive regulator of AKT. Nat Commun 8: 14422
39. Korkmaz G, Lopes R, Ugalde AP, Nevedomskaya E, Han R, Myacheva K, Zwart W, Elkon R, Agami R (2016) Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9. Nat Biotechnol 34:192–198
40. Kraft K, Geuer S, Will AJ, Chan WL, Paliou C, Borschiwer M, Harabula I, Wittler L, Franke M, Ibrahim DM et al (2015) Deletions, inversions, duplications: engineering of structural variants using CRISPR/Cas in mice. Cell Rep 10:833–839
41. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W et al (2001) Initial sequencing and analysis of the human genome. Nature 409:860–921
42. Li F, Cowley DO, Banner D, Holle E, Zhang L, Su L (2014) Efficient genetic manipulation of the NOD-Rag1-/-IL2RgammaC-null mouse by combining in vitro fertilization and CRISPR/Cas9 technology. Sci Rep 4:5290
43. Li J, Shou J, Guo Y, Tang Y, Wu Y, Jia Z, Zhai Y, Chen Z, Xu Q, Wu Q (2015) Efficient inversions and duplications of mammalian regulatory DNA elements and gene clusters by CRISPR/Cas9. J Mol Cell Biol 7:284–298
44. R619W mutation increases autoimmune diabetes. Diabetes 65:2134–2138
45. Long C, Amoasii L, Mireault AA, McAnally JR, Li H, Sanchez-Ortiz E, Bhattacharyya S, Shelton JM, Bassel-Duby R, Olson EN (2016) Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science 351:400–403
46. Maddalo D, Manchado E, Concepcion CP, Bonetti C, Vidigal JA, Han Y-C, Ogrodowski P, Crippa A, Rekhtman N, de Stanchina E et al (2014) In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system. Nature 516:423–427
47. Maillard AM, Ruef A, Pizzagalli F, Migliavacca E, Hippolyte L, Adaszewski S, Dukart J, Ferrari C, Conus P, Männik K et al (2015) The 16p11.2 locus modulates brain structures common to autism, schizophrenia and obesity. Mol Psychiatry 20:140–147
48. Marouli E, Graff M, Medina-Gomez C, Lo KS, Wood AR, Kjaer TR, Fine RS, Lu Y, Schurmann C, Highland HM et al (2017) Rare and low-frequency coding variants alter human adult height. Nature 542:186–190
49. McCarroll SA, Altshuler DM (2007) Copy-number variation and association studies of human disease. Nat Genet 39:S37–S42
50. Nelson CE, Hakim CH, Ousterout DG, Thakore PI, Moreb EA, Rivera RMC, Madhavan S, Pan X, Ran FA, Yan WX, et al (2016) In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science 351:403–407
51. No authors (1997) Mutant mice and neuroscience: recommendations concerning genetic background. Banbury Conference on genetic background in mice. Neuron 19:755–759
52. Ousterout DG, Kabadi AM, Thakore PI, Majoros WH, Reddy TE, Gersbach CA (2015) Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy. Nat Commun 6:6244
53. Perlman RL (2016) Mouse models of human disease: an evolutionary perspective. Evol Med Public Health 16:170–176
54. Pound P, Bracken MB (2014) Is animal research sufficiently evidence based to be a cornerstone of biomedical research?. BMJ 348:g3387
55. Ramírez-Solis R, Liu P, Bradley A (1995) Chromosome engineering in mice. Nature 378:720–724
56. Roberts R, Marian AJ, Dandona S, Stewart AFR (2013) Genomics in cardiovascular disease. J Am Coll Cardiol 61:2029–2037
57. Rosen B, Schick J, Wurst W (2015) Beyond knockouts: the International Knockout Mouse Consortium delivers modular and evolving tools for investigating mammalian genes. Mamm Genome 26:456–466
58. Ruf S, Symmons O, Uslu VV, Dolle D, Hot C, Ettwiller L, Spitz F (2011) Large-scale analysis of the regulatory architecture of the mouse genome with a transposon-associated sensor. Nat Genet 43:379–386
59. Sasaki M, Lange J, Keeney S (2010) Genome destabilization by homologous recombination in the germ line. Nat Rev Mol Cell Biol 11:182–195
60. Sharma A, Vella A (2017) Obstacles to translating genotype-phenotype correlates in metabolic disease. Physiology. 32:42–50
61. Shaw CJ (2004) Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease. Hum Mol Genet 13:R57–R64
62. Simon MM, Greenaway S, White JK, Fuchs H, Gailus-Durner V, Wells S, Sorg T, Wong K, Bedu E, Cartwright EJ et al (2013) A comparative phenotypic and genomic analysis of C57BL/6 J and C57BL/6 N mouse strains. Genome Biol 14:R82
63. Simpson EM, Linder CC, Sargent EE, Davisson MT, Mobraaten LE, Sharp JJ (1997) Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat Genet 16:19–27
64. Sittig LJ, Carbonetto P, Engel KA, Krauss KS, Barrios-Camacho CM, Palmer AA (2016) Genetic background limits generalizability of genotype-phenotype relationships. Neuron 91:1253–1259
65. Spitz F, Herkenne C, Morris MA, Duboule D (2005) Inversion-induced disruption of the Hoxd cluster leads to the partition of regulatory landscapes. Nat Genet 37:889–893
66. Stankiewicz P, Lupski JR (2002) Genome architecture, rearrangements and genomic disorders. TRENDS Genet 18:74–82
67. Tabebordbar M, Zhu K, Cheng JKW, Chew WL, Widrick JJ, Yan WX, Maesner C, Wu EY, Xiao R, Ran FA, et al (2016a) In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351:407–411
68. Tabebordbar M, Zhu K, Cheng, J.K.W., Chew WL, Widrick JJ, Yan WX, Maesner C, Wu EY, Xiao R, Ran FA et al (2016b) In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351:407–411
69. Tai, D.J.C., Ragavendran A, Manavalan P, Stortchevoi A, Seabra CM, Erdin S, Collins RL, Blumenthal I, Chen X, Shen Y et al (2016) Engineering microdeletions and microduplications by targeting segmental duplications with CRISPR. Nat Neurosci 19:517–522
70. Torres F, Barbosa M, Maciel P (2016) Recurrent copy number variations as risk factors for neurodevelopmental disorders: critical overview and analysis of clinical implications. J Med Genet 53:73–90
71. Turner DJ, Miretti M, Rajan D, Fiegler H, Carter NP, Blayney ML, Beck S, Hurles ME (2008) Germline rates of de novo meiotic deletions and duplications causing several genomic disorders. Nat Genet 40:90–95
72. Valdar W, Solberg LC, Gauguier D, Burnett S, Klenerman P, Cookson WO, Taylor MS, Rawlins, J.N.P., Mott R, Flint J (2006) Genome-wide genetic association of complex traits in heterogeneous stock mice. Nat Genet 38:879–887
73. Venter JC (2001) The sequence of the human genome. Science 291:1304–1351
74. Wang L, Shao Y, Guan Y, Li L, Wu L, Chen F, Liu M, Chen H, Ma Y, Ma X et al (2015) Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos. Sci Rep 5:17517
75. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R, Saemundsen E, Stefansson H, Ferreira MAR, Green T et al (2008) Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 358:667–675
76. Williams RW, Gu, J., Qi, S., Lu, L. (2001) The genetic structure of recombinant inbred mice: high-resolution consensus maps for complex trait analysis. Genome Biol. doi: 10.1186/gb-2001-2-11-research0046
77. Wu X, Hurst LD (2016) Determinants of the usage of splice-associated cis-motifs predict the distribution of human pathogenic SNPs. Mol Biol Evol 33:518–529
78. Yen S-T, Zhang M, Deng JM, Usman SJ, Smith CN, Parker-Thornburg J, Swinton PG, Martin JF, Behringer RR (2014) Somatic mosaicism and allele complexity induced by CRISPR/Cas9 RNA injections in mouse zygotes. Dev Biol 393:3–9
79. Yoshimi, K., Kunihiro, Y., Kaneko, T., Nagahora, H., Voigt, B., and Mashimo, T. (2016) ssODN-mediated knock-in with CRISPR-Cas for large genomic regions in zygotes. Nat Commun 7:10431
80. Young NS (2013) Mouse medicine and human biology. Semin Hematol 50:88–91
81. Zhang L, Jia R, Palange NJ, Satheka AC, Togo J, An Y, Humphrey M, Ban L, Ji Y, Jin H et al (2015) Large genomic fragment deletions and insertions in mouse using CRISPR/Cas9. PLoS ONE 10:e0120396
82. Zheng B, Mills AA, Bradley A (1999) A system for rapid generation of coat color-tagged knockouts and defined chromosomal rearrangements in mice. Nucleic Acids Res 27:2354–2360
83. Zhu QM, Ko KA, Ture S, Mastrangelo MA, Chen M-H, Johnson AD, O’Donnell CJ, Morrell CN, Miano JM, Lowenstein CJ (2017) Novel Thrombotic Function of a human SNP in STXBP5 revealed by CRISPR/Cas9 gene editing in mice. Arterioscler Thromb Vasc Biol 37:264–270